How to Buy Tirzepatide

→Tirzepatide is a synthetic dual-agonist peptide that activates both the GIP and GLP-1 receptors — two critical metabolic pathways involved in glucose regulation and appetite suppression.

Originally developed by Eli Lilly (marketed as Mounjaro®), tirzepatide has become one of the most studied peptides in metabolic research. Phase III trials have shown body-weight reductions of up to 22.5% and significant improvements in insulin sensitivity.

Available at Omrena in pack-of-10 lyophilised vials from 2 mg to 100 mg.

Tirzepatide’s dual mechanism targets two complementary pathways:

→GIP receptor activation — enhances insulin secretion, promotes fat oxidation, and increases lipolysis.

→GLP-1 receptor activation — reduces appetite, slows gastric emptying, and improves meal-time glucose control.

This dual approach produces greater metabolic effects than single-agonist GLP-1 peptides, with a comparable safety profile in published clinical data.

Every tirzepatide batch is independently tested for purity (≥99% by HPLC) and shipped lyophilised in sealed vials for maximum stability.

Free worldwide tracked shipping on all orders

Storage: –20 °C (long-term) or 2–8 °C (short-term). Shelf life: 24 months lyophilised.